Plugging the Holes in Hepatitis C Virus Antiviral Therapy

Total Page:16

File Type:pdf, Size:1020Kb

Plugging the Holes in Hepatitis C Virus Antiviral Therapy COMMENTARY Plugging the holes in hepatitis C virus antiviral therapy Stephen D. C. Griffin1 Institute of Molecular and Cellular Biology and Astbury Centre for Structural Molecular Biology, Faculty of Biological Sciences, University of Leeds, Mount Preston Street, Leeds LS2 9JT, United Kingdom growing number of RNA vi- ruses are now known to de- pend on virus-encoded ion channels for efficient produc- Ation of infectious virions and, in some cases, for the subsequent infection of naı¨ve cells. So-called viroporins are small hydrophobic proteins, usually less than 100 aa in length, and typically con- tain 1 or 2 transmembrane domains (TMDs); oligomerization is therefore necessary for the formation of ion channel complexes. By far the best- characterized viroporin is the M2 proton channel of influenza A virus, which is the target for the antiviral drugs aman- tadine and rimantadine (1). M2 sets a precedent for viroporins as therapeutic targets that has driven research into the ion channels of other clinically impor- tant viruses. In the light of rapid RNA virus evolution generating drug resis- tance, new compounds targeting viro- porins could be a valuable addition to future combinatorial antiviral strategies. Difficulties associated with working with membrane proteins in high-throughput systems lend support to a rational ap- proach for drug development based on the availability of high-resolution molecular structures. In this issue of PNAS, Luik et al. (2), describe the first structure of a complete viroporin complex, the p7 ion channel of hepatitis C virus (HCV), at 16-Å res- olution by using single-particle electron microscopy. The hexameric p7 complex (42 kDa) is one of the smallest objects Fig. 1. Potential sites of action for p7 inhibitors in the HCV life cycle. p7 could function during multiple stages to be visualized by these methods to of HCV particle production and may also play a role during infection. As such, inhibitors could block HCV at date which, combined with the hydro- multiple stages of the life cycle. At early stages (stage 1) p7 may interact with NS2 to promote efficient virion phobic nature of p7, renders this work assembly. p7 channels in secretory vesicles can prevent their acidification (stage 2), which could protect viral an impressive technical achievement. glycoproteins from premature fusogenic change or alter vesicle trafficking during exocytosis. The effect of p7 inhibitors on virus entry suggests that the ion channel is incorporated into secreted virions (stage 3). After virus Whereas high-resolution structural infor- entry (stage 4; for simplicity, only the CD81 receptor is shown), endosome acidification (stage 5) induces mation is available for M2 (3, 4), where fusogenic change in the viral glycoproteins and p7 potentially permits the passage of protons into the viral a short amino-terminal peptide is suffi- core, destabilizing the structure and promoting efficient uncoating (stage 6). cient to form the tetrameric channel complex, p7 channels comprise both TMDs from each protomer and so have served 3D structures not only provides replicate in chimpanzees (10), and com- thus far proved elusive in crystallo- clues to the gating of p7 channels, but pounds that block its activity in vitro graphic or NMR-based studies. This first could pave the way to future rational also inhibit particle production in cul- p7 structure is therefore of great impor- drug design, as a basis for deriving high- ture, validating it as a therapeutic target tance to the HCV field and provides resolution structures in the future, but (11, 12). The precise way in which p7 vital information on channel size, stoi- also in the short term by validating channel activity enhances particle pro- chiometry, and the orientation of p7 these molecular models for use in vir- duction, however, is unknown. Growing protomers within the channel complex. tual compound screening. evidence suggests that p7 behaves simi- The authors include an energy-mini- Like other viroporins, p7 has been mized model for the channel complex shown by several groups to display cat- that fits within the observed density and ion channel activity in vitro (5–7) and is Author contributions: S.D.C.G. wrote the paper. adopts a ‘‘flower petal’’ conformation now known to play a vital role during The author declares no conflict of interest. visible in the EM reconstructions. Com- virion secretion in culture (8, 9). Criti- See companion article on page 12712. bining molecular modeling with ob- cally, p7 is required for the virus to 1E-mail: s.d.c.griffi[email protected]. www.pnas.org͞cgi͞doi͞10.1073͞pnas.0906760106 PNAS ͉ August 4, 2009 ͉ vol. 106 ͉ no. 31 ͉ 12567–12568 Downloaded by guest on October 6, 2021 larly to M2 (13–15), which functions escape as effectively as combining virus- ing that a relatively small number of during both particle assembly and cell specific compounds. This eventuality is amino acid changes might be necessary entry: protecting viral glycoproteins well illustrated in HIV patients by the for HCV to escape this class of inhibi- from low pH during secretion, then, as a success of HAART (highly active anti- tors. The genetic barrier to such minor virion component, promoting un- retroviral therapy) and in vitro by the changes, however, may be raised com- coating of the viral core after exposure suppression of resistance in influenza by pared with enzymatic targets, given the to low pH in the endosome during in- using combinations of amantadine with requirement to retain interactions be- fection. Unlike influenza virus, however, oseltamivir (16). Future HCV treatment tween protomers involved in the forma- secreted HCV virions are relatively acid regimes, therefore, will no doubt entail tion of the intricate, flower-shaped, hexameric channel complex observed by stable, and it is not known whether p7 cocktails of several specific inhibitors, Luik et al. (2). resides in virions, although p7 inhibitors making the expansion of available drug What then, does the future hold for partially block virus entry (11). Much targets of paramount importance. the development of p7 inhibitors as work is needed to define precisely how To date, p7 inhibitors identified in HCV antivirals? The lessons learned p7 functions and so elucidate the stage vitro or in culture have been co-opted from HIV and from influenza must be of the virus life cycle where inhibitory from other virus systems, and no tailor- followed if the limited number of avail- compounds act (see Fig. 1). made compounds have been developed. able HCV-specific compounds is to pro- Is there a need for p7 inhibitors to be Adamantanes (amantadine and rimanta- vide ample coverage; use of these com- developed as new HCV therapies? Cer- dine) hail from influenza, whereas both pounds in isolation would no doubt lead tainly there is great demand for new alkylated iminosugars and amilorides to their becoming clinically inexpedient, virus-specific HCV drugs to treat the were originally targeted for HIV ther- as is the situation for rimantadine and 170 million individuals chronically in- apy. Of these, amantadine has been the influenza. Testing documented p7-spe- fected with the virus. A high level of subject of numerous clinical trials along- cific drugs in combination with HCV innate resistance and the rapid evolution side IFN/Rib, although many of these protease or polymerase inhibitors rather of viral quasispecies within individuals were instigated before identifying p7 as than IFN/Rib may provide the required render the current standard of care a target. Inclusion of amantadine over a proof of principle of their clinical effi- therapy comprising interferon ␣ (IFN␣) 48-week treatment has been shown to cacy and a means of rapidly adding and ribavirin (Rib) ineffective in around have little, if any, impact on patient end- drugs already validated in other systems 50% of cases. This lack of efficacy is of-treatment response, although retreat- to the anti-HCV repertoire. The Austra- largely because of the highly prevalent ing previous IFN/Rib nonresponders lian company Biotron has a new p7 in- hibitor, BIT225, in early stage Ib/IIa genotype 1 viruses, which are associated with IFN/Rib/amantadine triple therapy trials, but other examples of such com- with poor treatment outcome and more can improve results (17). This observa- pounds are not forthcoming. The expan- aggressive disease. The immune- tion has led to controversy over the use- sion of newly available p7 inhibitors will enhancing effect of IFN and the uncer- fulness of p7 inhibitors as effective HCV require either a convenient means of tain mode of action for Rib have treatments, yet it is highly likely that this measuring ion channel activity in high- therefore led researchers to pursue spe- lack of efficacy is due to the evolution throughput systems or a rational ap- cific HCV antivirals as a new generation or preexistence of amantadine-resistant proach achieved through an understand- of therapy. Drugs targeting the viral HCV quasispecies early during treat- ing of the channel complex structure. protease and polymerase are forthcom- ment (18). Supportive of this notion, The work of Luik et al. (2) represents ing, yet evidence already suggests that triple therapy nonresponders have been the first major advance toward this goal the virus rapidly becomes resistant shown to acquire specific mutations in and heightens optimism that p7 inhibi- where these drugs are used alone, just the p7 sequence not seen in IFN/Rib tors could become part of the standard as seen for the first HIV patients receiv- dual therapy (19), and amantadine of care HCV therapy. ing AZT (3Ј-azido-3Ј-deoxythymidine). monotherapy can transiently reduce vi- Combination of IFN/Rib with specific ral load (20). Accordingly, the effects of ACKNOWLEDGMENTS. Work on p7 in my labora- tory is funded by the United Kingdom Medical HCV antivirals is effective, but is un- p7 inhibitors on particle production in Research Council (G0700124), the Wellcome Trust likely to raise the genetic barrier to viral culture are strain specific (11), suggest- (082812), and the Royal Society (RG081138).
Recommended publications
  • Entry and Early Infection of Non-Segmented Negative Sense Rna Viruses
    University of Kentucky UKnowledge Theses and Dissertations--Molecular and Cellular Biochemistry Molecular and Cellular Biochemistry 2021 ENTRY AND EARLY INFECTION OF NON-SEGMENTED NEGATIVE SENSE RNA VIRUSES Jean Mawuena Branttie University of Kentucky, [email protected] Digital Object Identifier: https://doi.org/10.13023/etd.2021.248 Right click to open a feedback form in a new tab to let us know how this document benefits ou.y Recommended Citation Branttie, Jean Mawuena, "ENTRY AND EARLY INFECTION OF NON-SEGMENTED NEGATIVE SENSE RNA VIRUSES" (2021). Theses and Dissertations--Molecular and Cellular Biochemistry. 54. https://uknowledge.uky.edu/biochem_etds/54 This Doctoral Dissertation is brought to you for free and open access by the Molecular and Cellular Biochemistry at UKnowledge. It has been accepted for inclusion in Theses and Dissertations--Molecular and Cellular Biochemistry by an authorized administrator of UKnowledge. For more information, please contact [email protected]. STUDENT AGREEMENT: I represent that my thesis or dissertation and abstract are my original work. Proper attribution has been given to all outside sources. I understand that I am solely responsible for obtaining any needed copyright permissions. I have obtained needed written permission statement(s) from the owner(s) of each third-party copyrighted matter to be included in my work, allowing electronic distribution (if such use is not permitted by the fair use doctrine) which will be submitted to UKnowledge as Additional File. I hereby grant to The University of Kentucky and its agents the irrevocable, non-exclusive, and royalty-free license to archive and make accessible my work in whole or in part in all forms of media, now or hereafter known.
    [Show full text]
  • Viral Strategies to Arrest Host Mrna Nuclear Export
    Viruses 2013, 5, 1824-1849; doi:10.3390/v5071824 OPEN ACCESS viruses ISSN 1999-4915 www.mdpi.com/journal/viruses Review Nuclear Imprisonment: Viral Strategies to Arrest Host mRNA Nuclear Export Sharon K. Kuss *, Miguel A. Mata, Liang Zhang and Beatriz M. A. Fontoura Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA; E-Mails: [email protected] (M.A.M.); [email protected] (L.Z.); [email protected] (B.M.A.F) * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +1-214-633-2001; Fax: +1-214-648-5814. Received: 10 June 2013; in revised form: 27 June 2013 / Accepted: 11 July 2013 / Published: 18 July 2013 Abstract: Viruses possess many strategies to impair host cellular responses to infection. Nuclear export of host messenger RNAs (mRNA) that encode antiviral factors is critical for antiviral protein production and control of viral infections. Several viruses have evolved sophisticated strategies to inhibit nuclear export of host mRNAs, including targeting mRNA export factors and nucleoporins to compromise their roles in nucleo-cytoplasmic trafficking of cellular mRNA. Here, we present a review of research focused on suppression of host mRNA nuclear export by viruses, including influenza A virus and vesicular stomatitis virus, and the impact of this viral suppression on host antiviral responses. Keywords: virus; influenza virus; vesicular stomatitis virus; VSV; NS1; matrix protein; nuclear export; nucleo-cytoplasmic trafficking; mRNA export; NXF1; TAP; CRM1; Rae1 1. Introduction Nucleo-cytoplasmic trafficking of proteins and RNA is critical for proper cellular functions and survival.
    [Show full text]
  • Structure and Function of the Influenza a Virus Non-Structural Protein 1 Chang Woo Han1†, Mi Suk Jeong2†, and Se Bok Jang1*
    J. Microbiol. Biotechnol. (2019), 29(8), 1184–1192 https://doi.org/10.4014/jmb.1903.03053 Research Article Review jmb Structure and Function of the Influenza A Virus Non-Structural Protein 1 Chang Woo Han1†, Mi Suk Jeong2†, and Se Bok Jang1* 1Department of Molecular Biology, College of Natural Sciences, Pusan National University, Busan 46241, Republic of Korea 2Korea Nanobiotechnology Center, Pusan National University, Busan 46241, Republic of Korea Received: March 25, 2019 Revised: May 27, 2019 The influenza A virus is a highly infectious respiratory pathogen that sickens many people Accepted: June 3, 2019 with respiratory disease annually. To prevent outbreaks of this viral infection, an First published online understanding of the characteristics of virus-host interaction and development of an anti-viral June 4, 2019 agent is urgently needed. The influenza A virus can infect mammalian species including *Corresponding author humans, pigs, horses and seals. Furthermore, this virus can switch hosts and form a novel Phone: +82-51-510-2523; lineage. This so-called zoonotic infection provides an opportunity for virus adaptation to the Fax: +82-51-581-2544; E-mail: [email protected] new host and leads to pandemics. Most influenza A viruses express proteins that antagonize the antiviral defense of the host cell. The non-structural protein 1 (NS1) of the influenza A † These authors contributed virus is the most important viral regulatory factor controlling cellular processes to modulate equally to this work. host cell gene expression and double-stranded RNA (dsRNA)-mediated antiviral response. This review focuses on the influenza A virus NS1 protein and outlines current issues including the life cycle of the influenza A virus, structural characterization of the influenza A virus NS1, interaction between NS1 and host immune response factor, and design of inhibitors resistant pISSN 1017-7825, eISSN 1738-8872 to the influenza A virus.
    [Show full text]
  • Intergenotypic Replacement of Lyssavirus Matrix Proteins Demonstrates the Role of Lyssavirus M Proteins in Intracellular Virus A
    JOURNAL OF VIROLOGY, Feb. 2010, p. 1816–1827 Vol. 84, No. 4 0022-538X/10/$12.00 doi:10.1128/JVI.01665-09 Copyright © 2010, American Society for Microbiology. All Rights Reserved. Intergenotypic Replacement of Lyssavirus Matrix Proteins Demonstrates the Role of Lyssavirus M Proteins in Intracellular Virus Accumulationᰔ Stefan Finke,1* Harald Granzow,2 Jose Hurst,1† Reiko Pollin,1 and Thomas C. Mettenleiter1 Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Institutes of Molecular Biology1 and Infectology,2 D-17493 Greifswald–Insel Riems, Germany Received 8 August 2009/Accepted 21 November 2009 Lyssavirus assembly depends on the matrix protein (M). We compared lyssavirus M proteins from different genotypes for their ability to support assembly and egress of genotype 1 rabies virus (RABV). Transcomple- Downloaded from mentation of M-deficient RABV with M from European bat lyssavirus (EBLV) types 1 and 2 reduced the release of infectious virus. Stable introduction of the heterogenotypic M proteins into RABV led to chimeric viruses with reduced virus release and intracellular accumulation of virus genomes. Although the chimeras indicated genotype-specific evolution of M, rapid selection of a compensatory mutant suggested conserved mechanisms of lyssavirus assembly and the requirement for only few adaptive mutations to fit the heterogenotypic M to a RABV backbone. Whereas the compensatory mutant replicated to similar infectious titers as RABV M- expressing virus, ultrastructural analysis revealed that both nonadapted EBLV M chimeras and the compen- jvi.asm.org satory mutant differed from RABV M expressing viruses in the lack of intracellular viruslike structures that are enveloped and accumulate in cisterna of the degranulated and dilated rough endoplasmic reticulum compartment.
    [Show full text]
  • Incorporation of Hepatitis C Virus E1 and E2 Glycoproteins: the Keystones on a Peculiar Virion
    Viruses 2014, 6, 1149-1187; doi:10.3390/v6031149 OPEN ACCESS viruses ISSN 1999-4915 www.mdpi.com/journal/viruses Review Incorporation of Hepatitis C Virus E1 and E2 Glycoproteins: The Keystones on a Peculiar Virion Gabrielle Vieyres 1,*, Jean Dubuisson 2,3,4,5 and Thomas Pietschmann 1 1 Institute of Experimental Virology, Twincore, Center for Experimental and Clinical Infection Research, a Joint Venture between the Medical School Hannover and the Helmholtz Center for Infection Research, 30625 Hannover, Germany; E-Mail: [email protected] 2 Institut Pasteur de Lille, Center for Infection & Immunity of Lille (CIIL), F-59019 Lille, France; E-Mail: [email protected] 3 CNRS UMR8204, F-59021 Lille, France 4 Inserm U1019, F-59019 Lille, France 5 Université Lille Nord de France, F-59000 Lille, France * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +49-511-22-00-27-134; Fax: +49-511-22-00-27-139. Received: 18 December 2013; in revised form: 21 February 2014 / Accepted: 27 February 2014 / Published: 11 March 2014 Abstract: Hepatitis C virus (HCV) encodes two envelope glycoproteins, E1 and E2. Their structure and mode of fusion remain unknown, and so does the virion architecture. The organization of the HCV envelope shell in particular is subject to discussion as it incorporates or associates with host-derived lipoproteins, to an extent that the biophysical properties of the virion resemble more very-low-density lipoproteins than of any virus known so far. The recent development of novel cell culture systems for HCV has provided new insights on the assembly of this atypical viral particle.
    [Show full text]
  • Localization of Influenza Virus Proteins to Nuclear Dot 10 Structures in Influenza Virus-Infected Cells
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Available online at www.sciencedirect.com R Virology 310 (2003) 29–40 www.elsevier.com/locate/yviro Localization of influenza virus proteins to nuclear dot 10 structures in influenza virus-infected cells Yoshiko Sato,a Kenichi Yoshioka,a Chie Suzuki,a Satoshi Awashima,a Yasuhiro Hosaka,a Jonathan Yewdell,b and Kazumichi Kurodaa,c,* a Department of Virology and Immunology, Osaka University of Pharmaceutical Sciences, 4-20-1 Nasahara, Takatsuki, Osaka 569-1094, Japan b Laboratory of Viral Diseases, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD 20892, USA c Department of Immunology and Microbiology, Nihon University School of Medicine, Oyaguchi-kamicho, Itabashi-ku, Tokyo 173-8610, Japan Received 22 July 2002; returned to author for revision 19 August 2002; accepted 4 December 2002 Abstract We studied influenza virus M1 protein by generating HeLa and MDCK cell lines that express M1 genetically fused to green fluorescent protein (GFP). GFP-M1 was incorporated into virions produced by influenza virus infected MDCK cells expressing the fusion protein indicating that the fusion protein is at least partially functional. Following infection of either HeLa or MDCK cells with influenza A virus (but not influenza B virus), GFP-M1 redistributes from its cytosolic/nuclear location and accumulates in nuclear dots. Immunofluorescence revealed that the nuclear dots represent nuclear dot 10 (ND10) structures. The colocalization of authentic M1, as well as NS1 and NS2 protein, with ND10 was confirmed by immunofluorescence following in situ isolation of ND10.
    [Show full text]
  • The Role of MDM2–P53 Axis Dysfunction in the Hepatocellular
    Cao et al. Cell Death Discovery (2020) 6:53 https://doi.org/10.1038/s41420-020-0287-y Cell Death Discovery REVIEW ARTICLE Open Access TheroleofMDM2–p53 axis dysfunction in the hepatocellular carcinoma transformation Hui Cao1, Xiaosong Chen2, Zhijun Wang3,LeiWang1,QiangXia2 and Wei Zhang1 Abstract Liver cancer is the second most frequent cause of cancer-related death globally. The main histological subtype is hepatocellular carcinoma (HCC), which is derived from hepatocytes. According to the epidemiologic studies, the most important risk factors of HCC are chronic viral infections (HBV, HCV, and HIV) and metabolic disease (metabolic syndrome). Interestingly, these carcinogenic factors that contributed to HCC are associated with MDM2–p53 axis dysfunction, which presented with inactivation of p53 and overactivation of MDM2 (a transcriptional target and negative regulator of p53). Mechanically, the homeostasis of MDM2–p53 feedback loop plays an important role in controlling the initiation and progression of HCC, which has been found to be dysregulated in HCC tissues. To maintain long-term survival in hepatocytes, hepatitis viruses have lots of ways to destroy the defense strategies of hepatocytes by inducing TP53 mutation and silencing, promoting MDM2 overexpression, accelerating p53 degradation, and stabilizing MDM2. As a result, genetic instability, chronic ER stress, oxidative stress, energy metabolism switch, and abnormalities in antitumor genes can be induced, all of which might promote hepatocytes’ transformation into hepatoma cells. In addition, abnormal proliferative hepatocytes and precancerous cells cannot be killed, because of hepatitis viruses-mediated exhaustion of Kupffer cells and hepatic stellate cells (HSCs) and CD4+T cells by disrupting their MDM2–p53 axis.
    [Show full text]
  • Features of Nuclear Export Signals of NS2 Protein of Influenza D Virus
    viruses Article Features of Nuclear Export Signals of NS2 Protein of Influenza D Virus Lingcai Zhao, Huizhi Xia, Jingjin Huang, Yiqing Zheng, Chang Liu, Juan Su and Jihui Ping * MOE Joint International Research Laboratory of Animal Health and Food Safety, Engineering Laboratory of Animal Immunity of Jiangsu Province, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, China; [email protected] (L.Z.); [email protected] (H.X.); [email protected] (J.H.); [email protected] (Y.Z.); [email protected] (C.L.); [email protected] (J.S.) * Correspondence: [email protected] Received: 10 September 2020; Accepted: 23 September 2020; Published: 29 September 2020 Abstract: Emerging influenza D viruses (IDVs), the newest member in the genus Orthomyxovirus family, which can infect and transmit in multiple mammalian species as its relatives the influenza A viruses (IAVs). Additional studies of biological characteristics of IDVs are needed; here, we studied the characteristics of IDV nonstructural protein 2 (NS2), which shares the lowest homology to known influenza proteins. First, we generated reassortant viruses via reverse genetics to analyze the segment compatibility and gene interchangeability between IAVs and IDVs. Next, we investigated the locations and exact sequences of nuclear export signals (NESs) of the IDV NS2 protein. Surprisingly, three separate NES regions were found to contribute to the nuclear export of an eGFP fusion protein. Alanine scanning mutagenesis identified critical amino acid residues within each NES, and co-immunoprecipitation experiments demonstrated that their nuclear export activities depend on the CRM1-mediated pathway, particularly for the third NES (136-146aa) of IDV NS2.
    [Show full text]
  • Viroporins: Structure, Function and Potential As Antiviral Targets
    This is a repository copy of Viroporins: Structure, function and potential as antiviral targets. White Rose Research Online URL for this paper: http://eprints.whiterose.ac.uk/88837/ Version: Accepted Version Article: Scott, C and Griffin, S orcid.org/0000-0002-7233-5243 (2015) Viroporins: Structure, function and potential as antiviral targets. Journal of General Virology, 96 (8). pp. 2000-2027. ISSN 0022-1317 https://doi.org/10.1099/vir.0.000201 © 2015 The Authors. Published by the Microbiology Society. This is an author produced version of a paper published in Journal of General Virology. Uploaded in accordance with the publisher's self-archiving policy. Reuse Unless indicated otherwise, fulltext items are protected by copyright with all rights reserved. The copyright exception in section 29 of the Copyright, Designs and Patents Act 1988 allows the making of a single copy solely for the purpose of non-commercial research or private study within the limits of fair dealing. The publisher or other rights-holder may allow further reproduction and re-use of this version - refer to the White Rose Research Online record for this item. Where records identify the publisher as the copyright holder, users can verify any specific terms of use on the publisher’s website. Takedown If you consider content in White Rose Research Online to be in breach of UK law, please notify us by emailing [email protected] including the URL of the record and the reason for the withdrawal request. [email protected] https://eprints.whiterose.ac.uk/ Journal of General Virology Viroporins: structure, function and potential as antiviral targets --Manuscript Draft-- Manuscript Number: VIR-D-15-00200R1 Full Title: Viroporins: structure, function and potential as antiviral targets Article Type: Review Section/Category: High Priority Review Corresponding Author: Stephen D.
    [Show full text]
  • Hepatitis C Virus NS2 Protein Suppresses RNA Interference in Cells
    Virologica Sinica (2020) 35:436–444 www.virosin.org https://doi.org/10.1007/s12250-019-00182-5 www.springer.com/12250 (0123456789().,-volV)(0123456789().,-volV) RESEARCH ARTICLE Hepatitis C Virus NS2 Protein Suppresses RNA Interference in Cells 1 1,2 2,3 2,4 2,4 2 2,4 Hui Zhou • Qi Qian • Ting Shu • Jiuyue Xu • Jing Kong • Jingfang Mu • Yang Qiu • Xi Zhou1,2,4 Received: 12 October 2019 / Accepted: 1 November 2019 / Published online: 27 November 2019 Ó Wuhan Institute of Virology, CAS 2019 Abstract RNAi interference (RNAi) is an evolutionarily conserved post-transcriptional gene silencing mechanism and has been well recognized as an important antiviral immunity in eukaryotes. Numerous viruses have been shown to encode viral sup- pressors of RNAi (VSRs) to antagonize antiviral RNAi. Hepatitis C virus (HCV) is a medically important human pathogen that causes acute and chronic hepatitis. In this study, we screened all the nonstructural proteins of HCV and found that HCV NS2 could suppress RNAi induced either by small hairpin RNAs (shRNAs) or small interfering RNAs (siRNAs) in mammalian cells. Moreover, we demonstrated that NS2 could suppress RNAi via its direct interaction with double- stranded RNAs (dsRNAs) and siRNAs, and further identified that the cysteine 184 of NS2 is required for the RNAi suppression activity through a serial of point mutation analyses. Together, our findings uncovered that HCV NS2 can act as a VSR in vitro, thereby providing novel insights into the life cycle and virus-host interactions of HCV. Keywords Hepatitis C virus (HCV) Á NS2 Á Antiviral RNAi Á Viral suppressor of RNAi (VSR) Introduction ion channel protein, and nonstructural (NS) proteins NS2, NS3, NS4A, NS4B, NS5A and NS5B (Yin et al.
    [Show full text]
  • Hepatitis B Virus X Protein Binding to Hepsin Promotes C3 Production by Inducing IL-6 Secretion from Hepatocytes
    www.impactjournals.com/oncotarget/ Oncotarget Vol. 7, No. 7 Hepatitis B virus X protein binding to hepsin promotes C3 production by inducing IL-6 secretion from hepatocytes Mingming Zhang1, Jianxin Gu1, Chunyi Zhang1 1 Department of Biochemistry and Molecular Biology, Gene Research Center, School of Basic Medical Sciences, Fudan University, Shanghai 200032, China Correspondence to: Chunyi Zhang, e-mail: [email protected] Keywords: hepatitis B virus X protein, hepsin, complement C3, interleukin-6, hepatocellular carcinoma Received: August 06, 2015 Accepted: January 01, 2016 Published: January 08, 2016 ABSTRACT Hepatitis B virus (HBV) X protein (HBx) is an important effector for HBV- associated pathogenesis. In this study, we identified hepsin as an HBx-interacting protein and investigated the effects of hepsin on HBx-mediated complement component 3 (C3) secretion in hepatocytes. In vivo and in vitro binding between HBx and hepsin was confirmed by co-immunoprecipitation and Glutathione S-transferase pull-down assays. HBx synergized with hepsin to promote C3 production by potentiating interleukin-6 (IL-6) secretion. Knockdown of endogenous hepsin attenuated C3 and IL-6 secretion induced by HBx in hepatic cells. In addition, levels of hepsin protein correlated positively with C3 expression in human non-tumor liver tissues. Further exploration revealed that HBx and hepsin increased C3 promoter activity by up-regulating the expression and phosphorylation of the transcription factor CAAT/enhancer binding protein beta (C/EBP-β), which binds to the IL-6/ IL-1 response element in the C3 promoter. HBx and hepsin synergistically enhanced IL-6 mRNA levels and promoter activity by increasing the nuclear translocation of nuclear factor kappaB (NF-κB).
    [Show full text]
  • Matrix Protein of VSV New Jersey Serotype Containing Methionine To
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Virology 357 (2007) 41–53 www.elsevier.com/locate/yviro Matrix protein of VSV New Jersey serotype containing methionine to arginine substitutions at positions 48 and 51 allows near-normal host cell gene expression ⁎ Gyoung Nyoun Kim, C. Yong Kang Department of Microbiology and Immunology, The University of Western Ontario, Siebens-Drake Research Institute, London, Ontario, Canada N6G 2V4 Received 27 March 2006; returned to author for revision 27 April 2006; accepted 17 July 2006 Available online 7 September 2006 Abstract The matrix (M) protein of vesicular stomatitis virus (VSV) plays significant roles in the replication of VSV through its involvement in the assembly of virus particles as well as by facilitating the evasion of innate host cell defense mechanisms. The presence of methionine at position 51 (M51) of the matrix (M) protein of the VSV Indiana serotype (VSVInd) has been proven to be crucial for cell rounding and inhibition of host cell gene expression. The M protein of VSVInd with the substitution of M51 with arginine (R:M51R) results in the loss of inhibitory effects on host cell gene expression. The VSVInd expressing the M(M51R) protein became the attractive oncolytic virus which is safer and more tumor-specific because the normal cells can clear the mutant VSVInd easily but tumor cells are susceptible to the virus because a variety of tumor cells lack innate antiviral activities. We have studied the role of the methionines at positions 48 and 51 of the M protein of the New Jersey serotype of VSV (VSVNJ) in the induction of cytopathic effects (CPE) and host cell gene expression.
    [Show full text]